Washington Examiner – The Food and Drug Administration sent a letter to online retail giants Thursday asking them to limit the sale of an over-the-counter, anti-diarrheal medicine that drug users are taking to mimic a euphoric high from opioids.
ABC News – A project to build a massive oil-by-rail terminal in southwest Washington officially ended Tuesday when the project's developers and the Port of Vancouver terminated a lease for a site along the Columbia River.
The Hill – Four Republican senators representing oil and farm states failed to come to an agreement on changes to the nation’s biofuel mandate during a White House meeting with President Trump on Tuesday.
R&D Magazine – Over 100 scientists from 25 research institutions and industries in 12 different European Countries have completed one of the first attempts to understand the risks nanomaterials carry throughout their life-cycle.
FedScoop – The Government Accountability Office’s new five-year strategic plan calls for more federal research and development spending to drive the potential of five emerging technologies it says could change society.
Utility Dive – FERC Order 841 could be a landmark decision for the storage industry but Brattle's report is a reminder that economics and policy will also need to be favorable in order for storage to reach its full potential.
The New York Times – In an effort to encourage new treatments for opioid addiction, the Food and Drug Administration plans to begin permitting pharmaceutical companies to sell medications that help temper cravings, even if they don’t fully stop addiction.